Exposee-Number
2819

Novel therapeutic approach for arthritis disease

Osteoarthritis is the most common arthritic disease and can occur in all joints, associated with chronic pain and bone loss.
Currently, no curative treatment is available.
→ Unmet medical need to inhibit bone loss and associated joint pain

Department
Biology


Subject area
Extracellular Vesicles & miRNA Research (Saul Lab)


Patent number
DE102019122014


Contact person
Dr. Meike Saul
saul@bio.tu-darmstadt.de
+49 6151 16-22005

Downloads

The exposé is available to download here as a PDF.

State: 17.11.2026 | Pdf | 247 Kb

Novel therapeutic approach for arthritis disease

State: 17.11.2026 | Pdf | 199 Kb

Our technology: miR-574-5p
Inhibition of osteoclast differentiation
→ Reduction of bone resorption
Inhibition of pain mediators
→ Reduction of inflammation and pain
Innovativer Therapieansatz: RNA-basierte Therapeutika
→ RNA therapeutics can intervene much earlier in the disease process than conventional drugs
→ Prototype: peptide nucleic acid (PNA)-based inhibitor